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3D Printing in Pharmaceutical 
Sector: An Overview
Asad Ali, Usama Ahmad and Juber Akhtar
Abstract
The pharmaceutical industry is moving ahead at a rapid pace. Modern technology 
has enabled the development of novel dosage forms for targeted therapy. However, 
the fabrication of novel dosage forms at industrial scale is limited and the industry 
still runs on conventional drug delivery systems, especially modified tablets. The 
introduction of 3D printing technology in the pharmaceutical industry has opened 
new horizons in the research and development of printed materials and devices. The 
main benefits of 3D printing technology lie in the production of small batches of 
medicines, each with tailored dosages, shapes, sizes, and release characteristics. The 
manufacture of medicines in this way may finally lead to the concept of personalized 
medicines becoming a reality. This chapter provides an overview of how 3D printed 
technology has extended from initial unit operations to developed final products.
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1. Introduction to 3D printing
Gaining immense interest both in academic and industrial sector is the concept of 
three dimensional (3D) printing (3DP) technologies. Domains like aerospace, engi-
neering, FMCG, architecture, military, fashion industry, chemical industry, and medi-
cal field are by no way untouched by this technology [1, 2]. 3DP has a wide range of 
applications like tissue design, printing of organ, diagnostics, manufacture of biomed-
ical devices, and the design of drug and delivery systems in the medical field [3, 4]. 
From the data originated by various techniques like computed tomography (CT) scan 
and magnetic resonance imaging (MRI), complex anatomical and medical structures 
according to the need of patient can be fabricated [5, 6]. Replacing and repairing the 
defective organs like kidney, heart etc. or all together creating a new organ that mimics 
the same functions as that of original are some additional uses of this technology [7]. 
This technology is so widespread that its applications include things that are an integral 
part of human life like clothing, eyeglasses, jewelry, parts of cars, and drugs that can be 
printed in almost any geometry and shape as per the requirement of the user [8].
In this technology a concept is transformed into prototype by taking help from 
3D computer-aided design (CAD) files, hence digitally controlled and customized 
product can be fabricated [9]. This technology utilizes a bottom-up approach in 
which layers of materials like living cells, wood, alloy, thermoplastic, metals etc.  
are placed on top of each other in order to make the required 3D object [10]. 
Therefore, 3D printing is also known by other terminologies such as layered manu-
facturing, additive manufacturing, computer automated manufacturing, rapid 
prototyping, or solid freeform technology (SFF) [9].
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In subtractive methodology or conventional method, the product is designed from 
the bulk substance and due to non-advanced tools used non-standard geometries 
and objects made from many materials cannot be made with high quality [11, 12]. In 
contrast to the conventional method, 3DP technology is more automated, rapid and 
easy to use, customized and sophisticated and cost-effective [13–15].
2. 3D printing procedure
First, a virtual 3D design of an object using digital design software like Onshape, 
Solidworks, Creo parametric, Autocad, Autodesk etc. is created [2, 16, 17].
This digital model is then converted to (.STL) digital file format which stands 
for standard tessallation language or stereolithography [2].
Triangulated facets give information regarding the surface of the 3D model that 
is present in the (.STL) file [2].
The (.STL) file is converted into G file by slicing the design into a series of 
2D horizontal cross-sections by the help of specialized slicer software, which is 
installed in the 3D printer (Tables 1–2).
Now the print head is moved in the x-y axis to create the base of the 3D object.
The print head is now allowed to move in the z-axis, thereby depositing the 
layers sequentially of the desired material, hence creating a complete 3D object 
[2, 9].
Maximum numbers of 3D printing technologies are compatible with (.STL) file 
format. Some errors might occur during the conversion of the 3D model to .STL 
digital file; therefore, software like Magics (Materialise) can be employed to correct 
the errors during conversion. File formats other than .STL like additive manufactur-
ing file format (AMF) and 3D manufacturing format (3MF) are used as .STL does 
not have information regarding the type of material, its color, texture, properties, 
and other features [18].
3. Types of 3D printing technology
3.1 Fused deposition modeling (FDM)
The process involves the selection of the desired polymer, which is melted and 
forced through a movable heated nozzle. Along the entire 3 axis (i.e., x-y-z), the 
polymer is laid down layer by layer, which on solidification gives the exact shape 
as was designed by computer aided design models. Multiple dosage forms like 
implants, zero-order release tablets etc. that include polymer as a part of their 
formulation can be made by this method [9, 19–21].
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Year Major development
1980 Dr. Hideo Kodama filed first patent for RP technology
1984 Stereo lithography apparatus (SLA) was invented by Charles Hull
1986 Carl Deckard invented apparatus for producing parts by selective sintering
1989 Patent was granted to Carl Deckard for SLA
1990 Fused deposition modeling (FDM)
1992 First SLA machine was produced using 3D system
1993 3D printing patent was granted to E.M Sachs
1996 Clinical application of biomaterials for tissue regeneration
1999 Luke Massella received first 3D printed bladder which was an amalgamation of 3D printed 
biomaterials and his own cells
2000 MCP technologies introduced the SLM technology
2002 Miniature functional kidney was fabricated
2003 Term organ printing was coined
2004 Dr. Bowyer conceived the RepRap concept of an open-source, self-replicating 3D printer
2005 First color 3D printer was introduced by Z Corp
2007 Selective layer customization and on-demand manufacturing of industrial parts
2009 Organovo, Inc., announced the release of data on the first fully bioprinted blood vessels
2011 3D printing was applied in gold and silver
World’s first 3D printed car, robotic aircarft was introduced
2012 Extrusion-based bioprinting for an artificial liver
3D printed prosthetic jaw was implanted
2013 SolidConcepts produced a 3D printed metal gun
2014 Implementation of multi-arm bioprinter to integrate tissue fabrication with printed vasculature
2015 First 3D printed pill was approved by US FDA
Organovo announced the release of data on the first fully bioprinted kidney
Table 1. 
Historical development in the field of 3D printing (table adapted from Ref. [8]).
3D printing technology 
used
Formulations API Ref.
Semi-solid extrusion (SSE) Bi-layered tablets 
(polypill)
Guaifenesin [30]
Multiactive tablets 
(polypill)
Nifedipine, Glipizide, and 
captopril
[31]
Stereolithography (SLA) Hydrogels Ibuprofen [32]
Facial mask Salicylic acid [33]
Selective layer sintering 
(SLS)
Tablets Paracetamol [34]
Drug delivery device Progesterone [35]
Fused deposition modeling 
(FDM)
Caplets Caffeine [36]
Tablets Hydrochlorothiazide [37]
Oral films Aripiprazole [38]
Pharmaceutical Formulation Design - Recent Practices
4
3.2 Thermal inkjet (TIJ) printing
It involves the heating of ink fluid by the help of micro-resistor, thereby creating 
a bubble of vapor that nucleates and upon expansion forces the ink to drop out of 
the nozzle. Dispensing of extemporaneous preparation/solution of drug onto 3D 
scaffolds is an area where this technique can be employed [22, 23].
3.3 Inkjet printing
It is a powder-based 3D printing that utilizes powder as a substrate on which 
layer by layer different combinations of active ingredients and ink is sprayed 
which is of varying droplet size that eventually solidifies into solid dosage form 
[9, 19, 24–28].
3.4 Direct-wise
It encompasses a pattern-generating device that moves as per the guidance of 
computer-controlled translational stage so that layers after layers are put on in order 
to achieve a 3D microstructure [29].
3.5 Zip dose
This technology provides a personalized dose in additional to the delivery of a 
high drug-load with high disintegration and dissolution levels by manufacturing 
highly porous material [25].
3.6 Vat photopolymerization
It is light-induced polymerization where materials like photopolymers, radia-
tion-curable resins, and liquid are collected in vats, which are successively cured 
into layers, one layer at a time by irradiating with a light source, thereby providing 
a 2D patterned layer. This involves techniques such as stereolithography (SLA), 
digital light processing (DLP), and continuous direct light processing (CDLP). 
3D printing technology 
used
Formulations API Ref.
Binder jet printing Tabular devices Methylene blue and alizarin yellow 
(dyes)
[39]
Cubic tabular devices Pseudoephedrine [40]
Tablets Chlorpheniramine meleate and 
fluorescein
[41]
Orodispersible tablets Levetiracetam [42]
Inkjet 3D printing Implant Levofloxacin [43]
3D printing machine Multidrug implant Rifampicin and isoniazid [44]
Inkjet 3D printing Nanosuspension Folic acid [45]
Thermal inkjet (TIJ) printing Solution Salbutamol sulfate [22]
Inkjet 3D printing Nanoparticle Rifampicin [27]
Table 2. 
Pharmaceutical preparations that were developed by 3DP technology.
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Depending on the orientation of light source and the surface where polymer-
ization of the photoactive resin occurs, SLA can be divided into two different 
configurations:
1. Bath configuration (free surface approach)
2. Bat configuration (constrained surface approach) [2].
Advantages of 3D printing in the pharmaceutical field:
1. Enhanced productivity: 3D printing works more quickly in contrast to tradi-
tional methods especially when it comes to fabrication of items like prosthet-
ics and implants with an additional benefit of better resolution, repeatability, 
more accuracy, and reliability [7].
2. Customization and personalization: One of the pioneer benefits of this 
technology is the liberty of fabrication of customized medical equipment and 
products. Customized implants, prosthetics, surgical tools, fixtures can be a 
great boon to patients as well as physicians [7].
3. Increased cost efficiency: Objects produced by 3D printing are of low cost. 
It is an advantage for small-scale production units or for companies that 
produce highly complex products or parts because almost all ingredients are 
inexpensive [46, 47].
By eradicating the use of unnecessary resources, manufacturing cost can also be 
reduced. For instance, 20-mg tablets could be potentially formulated as 1-mg tablets 
as per need [19].
4. 3DP allows controlled size of droplets, complex drug release profiles, strength 
of dosage and multi-dosing [44, 48, 49].
Disadvantages of 3D Printing:
1. In inkjet printing, proper flow of ink can only be achieved with ink that has 
precise viscosity [50].
2. Ink formulation material should have the property of self-binding but should 
not bind to other printer elements. In some formulation when the ink does 
not possess adequate self-binding property or it binds with other elements of 
printer then the resultant formulation does not have required hardness [51].
3. Rate of drug release may get affected due to binding of ink with other printer 
materials [52].
4. Medical applications of 3D printing
4.1 Bioprinting of tissues and organs
One of the critical medical issues is the failure of organs and tissues as a result 
of accident, congenital defects, aging etc (Figure 1) and the current resolution for 
this problem is organ transplant from dead or living donors. However, only few 
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fortunate people receive organs and the rest die due to donor shortage. Moreover, 
the procedures for organ transplants are so expensive that it is out of reach of com-
mon people. Another problem with transplant surgery is that donors with tissue 
match are difficult to find [7, 53].
The solution to this problem lies in the fact that the required tissue or organ 
should be fabricated using the patient’s own body cells, which would decrease the 
risk of tissue or organ rejection; moreover, the requirement for immunosuppressant 
will also be greatly reduced [7, 54].
In the conventional method of tissue engineering from a small tissue sample, 
stem cells are isolated, amalgamated with growth factor, and then multiplied in the 
laboratory. Then the cells are seeded onto scaffolds that direct cell proliferation and 
differentiation into a functioning tissue.
Placement of cell with accuracy, digitally controlled speed, drop volume, resolu-
tion, concentration of cells and diameter of printed cell are some of the additional 
advantages that 3D bioprinting offers over traditional tissue engineering [2, 54].
Depending upon the porosity, the type of tissue, and required strength, various 
materials are present to make the scaffolds. Among all materials, hydrogels are said 
to be the most suitable for building soft tissues [2, 55].
No doubt that organ printing is still in the phase of development but several 
researches have demonstrated its concept with proof. Scientists have built an arti-
ficial ear, cartilage and bone, and heart valve by the help of 3D printers [2, 47, 55]. 
Wang et al. used 3D bioprinting technology to deposit different cells within various 
biocompatible hydrogels to produce an artificial liver [54].
As with the increasing interest of researcher and academician and with vast 
potential of this technology it can possibly unfold new potential therapeutic drugs 
thereby greatly cutting research cost and time [7].
4.2 Unique dosage forms
Infinite dosage forms can be created using 3D printing. Inkjet-based 3D print-
ing and inkjet powder-based 3D printing are the two main printing technologies 
Figure 1. 
Different medical applications of 3D printing technology.
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employed in the pharmaceutical industry. Microcapusles, antiobiotic printed 
micropatterns, mesoporous bioactive glass scaffolds, nanosuspensions, and hyal-
uronan-based synthetic extracellular matrices are some of the novel dosage forms 
formulated using 3D printing [53] (Table 3).
4.3 Personalized drug dosing
Increasing the efficacy of drugs and at the same time reducing the chances of 
adverse reaction should be the aim of drug development, which can be achieved by 
using 3D printing to fabricate personalized medications [7, 26, 53].
Oral tablets are prepared by mixing, milling, and dry and wet granulation of 
powder ingredients, which are eventually compressed to form tablets; till today, 
tablets are the most popular dosage form because of the ease of preparation, 
good patient compliance and accurate dosing and because they are painless. 
However, no method is available that can prepare personalized solid dosage 
forms like tablets.
In the traditional way of preparing tablets, drugs can easily undergo degrada-
tion if proper guidelines are not followed, leading to altered therapeutic value of 
the final product. Moreover, these conventional methods cannot be used to prepare 
customized dosage forms that possess long-lasting stability, novel drug release 
profile, and detailed geometries [26].
Drugs with narrow therapeutic index can easily be prepared using 3D printing; 
and, by knowing the patient’s pharmacogenetic profile and other characteristics like 
age, race etc., optimal dosage can be given to the patient [53].
Preparation of entirely new formulation is another vital potential of 3D print-
ing for instance fabrications of pills that have a blend of more than one active 
pharmaceutical ingredient or dispensed as multi-reservoir printed tablets. Hence 
patients suffering from more than one disease can get their formulation ready in 
one multi-dose form at the healthcare point itself, thereby providing personalized 
and accurate dose to the patient with better or best compliance [26].
4.4 Complex drug release profile
In most conventional compressed dosage forms, a simple drug release profile 
which is a homogenous mixture of active ingredients is observed. Whereas in 3D 
printed dosage forms, a complex drug release profile that allows fabrication of 
complex geometries that are porous and loaded with multiple drugs throughout, 
Active pharmaceutical ingredients Inactive pharmaceutical ingredients
Vancomycin Glycerin
Ofloxacin Methanol
Folic acid Acetone
Dexamethasone Surfactants (likeTween 20)
Theophylline Kollidon SR
Acetaminophen Ethanol-dimethyl sulfoxide
Paclitaxel Propylene glycol
Tetracycline etc. Cellulose etc.
Table 3. 
List of active and inactive ingredients used in 3D printing.
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surrounded by barrier layers that modulate release, is found [55]. One example 
is the printing of a multilayered bone implant with a distinct drug release profile 
alternating between rifampicin and isoniazid in a pulse release mechanism. 3D 
printing has also been used to print antibiotic micropatterns on paper, which have 
been used as drug implants to eradicate Staphylococcus epidermidis [53].
In a research concerning drug release profiles, chlorpheniramine maleate was 
3D printed onto a cellulose powder substrate in amounts as small as 10–12 moles to 
demonstrate that even a minute quantity of drug could be released at a specified 
time. This study displayed improved accuracy for the release of very small drug 
doses compared with conventionally manufactured medications [53].
5. Customized implants and prostheses
By the support of MRI, CT scan, and X-ray and its translation into .stl 3D print 
files, implants and prostheses of any possible shape can be made [1, 7, 55].
Standard as well as complex surgical implants and prosthetic limbs can be made 
as per need in time as less as 24 hours. Spinal dental and hip implants have been 
fabricated so far but their validation is a time-consuming process. Previously, in 
order to achieve a desired shape and size that fits perfectly, surgeons had to craft 
metal and plastic pieces and perform bone grafting or use drill machines to modify 
the implants [2, 7]. This also stands correct in neurosurgery cases due to the irregu-
lar shape of the skull whose standardization is a complex procedure.
Some examples of commercially and clinically successful 3D printed implants 
and prostheses are as follows:
a. First 3D printed titanium mandibular porsthesis was implanted successfully at 
BIOMED Research Institute in Belgium [1].
b. Dental, orthopedic, maxillofacial, and spinal implants are manufactured by a 
company named Layer Wise [55].
c. Invisalign braces is another successful commercial use of 3D printing.
By using silver nanoparticles, chondrocytes, and silicon, a prosthetic ear was 
made out of 3D printing technology that was able to detect electromagnetic fre-
quencies. The impact of this technology is so extensive in the field of hearing aids 
that today 99% of customized hearing aids are made using 3D printers, because, as 
everyone’s ear canal has a different shape, this technology is able to provide perfect 
fit for each receiver and, moreover, the devices can be produced efficiently and cost 
effectively [7].
6. Anatomical models for surgical preparations
In order to have successful medical procedures, knowledge about patients’ 
specific anatomy before medical surgery is essential due to variations in individual 
and complex human anatomy. 3D printed models have helped extensively in this 
respect, making them a vital tool for surgical methods [1, 55].
One of the most complicated structures of human body is the head, whose 3D 
printed neuro-anatomical models are of great help to neurosurgeons. Sometimes, 
it is very difficult to gain detailed information about the connections between skull 
architecture, cerebral structure, cranial nerves, and vessels from radiographic 2D 
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images only and even a slight error in the medical procedure can be fatal. Here 
comes the role of 3D models, which are more realistic and provide in detail com-
parison and contrast between a normal brain structure and a brain with deformity 
or lesions, which suggest the surgeons more safe procedures to follow.
• For liver transplant, Japan’s Kobe University Hospital had used 3D printed 
models by using replica of patients’ own organ, to find out how to precisely 
craft a donor liver with least tissue loss [1].
• 3D printed model of calcified aorta for surgical planning of plaque removal 
was used by surgeons [55].
• To study aerosol drug delivery to lungs, airways of premature infants was 
reconstructed using 3D printing technology [55].
7. Conclusion
3D printing technology is a valuable and potential tool for the pharmaceutical 
sector, leading to personalized medicine focused on the patients’ needs. It offers 
numerous advantages, such as increasing the cost efficiency and the manufacturing 
speed. 3D printing has revolutionized the way in which manufacturing is done. It 
improves the design manufacturing and reduces lead time and tooling cost for new 
products. This chapter has summarized different fabrication methods and some 
notable applications of 3D printing in the healthcare sector, especially in pharma-
ceutical sciences.
Author details
Asad Ali, Usama Ahmad* and Juber Akhtar
Faculty of Pharmacy, Integral University, Lucknow, India
*Address all correspondence to: usamaahmad.10@outlook.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Pharmaceutical Formulation Design - Recent Practices
References
[1] Klein GT, Lu Y, Wang MY. 3D 
printing and neurosurgery--ready 
for prime time? World Neurosurgery. 
2013;80(3-4):233-235
[2] Gross BC, Erkal JL, Lockwood SY, 
Chen C, Spence DM. Evaluation of 
3D printing and its potential impact 
on biotechnology and the chemical 
sciences. Analytical Chemistry. 
2014;86(7):3240-3253
[3] Chia HN, Wu BM. Recent advances 
in 3D printing of biomaterials. Journal 
of Biological Engineering. 2015;9(1):4
[4] Liaw CY, Guvendiren M. Current 
and emerging applications of 3D 
printing in medicine. Biofabrication. 
2017;9(2):024102
[5] Rengier F, Mehndiratta A, Von 
Tengg-Kobligk H, Zechmann CM, 
Unterhinninghofen R, Kauczor HU, 
et al. 3D printing based on imaging 
data: Review of medical applications. 
International Journal of Computer 
Assisted Radiology and Surgery. 
2010;5(4):335-341
[6] Giannopoulos AA, 
Mitsouras D, Yoo SJ, Liu PP, 
Chatzizisis YS, Rybicki FJ. Applications 
of 3D printing in cardiovascular 
diseases. Nature Reviews Cardiology. 
2016;13(12):701
[7] Schubert C, Van Langeveld MC, 
Donoso LA. Innovations in 3D printing: 
A 3D overview from optics to organs. 
The British Journal of Ophthalmology. 
2014;98(2):159-161
[8] Vinogradov P. 3D printing in 
medicine: Current challenges and 
potential applications. In: Ahmad NP, 
Gopinath P, Dutta D, editor. 3D Printing 
Technology in Nanomedicine. Missouri: 
Elsevier Inc.; 2019. p. 1
[9] Ventola CL. Medical applications 
for 3D printing: Current and projected 
uses. Pharmacy and Therapeutics. 
2014;39(10):704
[10] Randolph SA. 3D printing: What 
are the hazards? Workplace Health and 
Safety. 2018;66(3):164
[11] Campbell T, Williams C, Ivanova O, 
Garrett B. Could 3D printing change the 
world. In: Technologies, Potential, and 
Implications of Additive Manufacturing. 
Washington, DC: Atlantic Council; 
2011. p. 3
[12] Hwang HH, Zhu W, Victorine G, 
Lawrence N, Chen S. 3D-printing of 
functional biomedical microdevices via 
light-and extrusion-based approaches. 
Small Methods. 2018;2(2):1700277
[13] Peterson GI, Larsen MB, 
Ganter MA, Storti DW, Boydston AJ. 
3D-printed mechanochromic materials. 
ACS Applied Materials and Interfaces. 
2014;7(1):577-583
[14] Anciaux SK, Geiger M, 
Bowser MT. 3D printed micro free-flow 
electrophoresis device. Analytical 
Chemistry. 2016;88(15):7675-7682
[15] Wang X, Ao Q , Tian X, et al. 3D 
bioprinting technologies for hard tissue 
and organ engineering. Materials. 
2016;9:802
[16] Roopavath UK, Kalaskar DM. 
Introduction to 3D printing in medicine. 
In: Deepak MK, editor. 3D Printing in 
Medicine. Cambridge, United States: 
Woodhead Publishing; 2017. pp. 1-20
[17] Patwardhan A. How 3D printing 
will change the future of borrowing 
lending and spending? In: David 
Lee Kuo Chuen Robert Deng, editor. 
Handbook of Blockchain, Digital 
Finance, and Inclusion, Volume 2. 
London, United Kingdom: Academic 
Press; 2018. pp. 493-520
11
3D Printing in Pharmaceutical Sector: An Overview
DOI: http://dx.doi.org/10.5772/intechopen.90738
[18] Gibson I, Rosen D, 
Stucker B. Additive Manufacturing 
Technologies, 3D Printing, Rapid 
Prototyping, and Direct Digital 
Manufacturing. New York Heidelberg 
Dordrecht London: Springer; 2010
[19] Katakam P, Dey B, Assaleh FH, 
Hwisa NT, Adiki SK, Chandu BR, et al. 
Top-down and bottom-up approaches 
in 3D printing technologies for drug 
delivery challenges. Critical Reviews 
in Therapeutic Drug Carrier Systems. 
2015;32(1):61-87
[20] Goyanes A, Buanz AB, Hatton GB, 
Gaisford S, Basit AW. 3D printing 
of modified-release aminosalicylate 
(4-ASA and 5-ASA) tablets. European 
Journal of Pharmaceutics and 
Biopharmaceutics. 2015;89:157-162
[21] Masood SH. Application of fused 
deposition modelling in controlled drug 
delivery devices. Assembly Automation. 
2007 Aug 7;27(3):215-221
[22] Buanz AB, Saunders MH, 
Basit AW, Gaisford S. Preparation 
of personalized-dose salbutamol 
sulphate oral films with thermal ink-jet 
printing. Pharmaceutical Research. 
2011;28(10):2386
[23] Meléndez PA, Kane KM, Ashvar CS, 
Albrecht M, Smith PA. Thermal inkjet 
application in the preparation of 
oral dosage forms: Dispensing 
of prednisolone solutions and 
polymorphic characterization by 
solid-state spectroscopic techniques. 
Journal of Pharmaceutical Sciences. 
2008;97(7):2619-2636
[24] Sachs E, Cima M, Cornie J. Three 
dimensional printing: Rapid tooling and 
prototypes directly from a CAD model. 
Journal of Manufacturing Science and 
Engineering. 1992;114:481-488
[25] Khaled SA, Burley JC, 
Alexander MR, Roberts CJ. Desktop 3D 
printing of controlled release 
pharmaceutical bilayer tablets. 
International Journal of Pharmaceutics. 
2014;461(1-2):105-111
[26] Gu Y, Chen X, Lee JH, Monteiro DA, 
Wang H, Lee WY. Inkjet printed 
antibiotic-and calcium-eluting 
bioresorbable nanocomposite 
micropatterns for orthopedic implants. 
Acta Biomaterialia. 2012;8(1):424-431
[27] Sandler N, Määttänen A, 
Ihalainen P, Kronberg L, Meierjohann A, 
Viitala T, et al. Inkjet printing of drug 
substances and use of porous substrates-
towards individualized dosing. 
Journal of Pharmaceutical Sciences. 
2011;100(8):3386-3395
[28] Lewis JA, Gratson GM. Direct 
writing in three dimensions. Materials 
Today. 2004;7(7-8):32-39
[29] Pharmaceuticals A. FDA approves 
the first 3D printed drug product. 
Aprecia Introduces its First Product 
Using the ZipDose® Formulation 
Platform for the Treatment of Epilepsy; 
2015
[30] Khaled SA, Burley JC, 
Alexander MR, Yang J, Roberts CJ. 3D 
printing of tablets containing multiple 
drugs with defined release profiles. 
International Journal of Pharmaceutics. 
2015;494(2):643-650
[31] Martinez PR, Goyanes A, Basit AW, 
Gaisford S. Fabrication of drug-loaded 
hydrogels with stereolithographic 
3D printing. International Journal of 
Pharmaceutics. 2017;532(1):313-317
[32] Goyanes A, Det-Amornrat U, 
Wang J, Basit AW, Gaisford S. 3D 
scanning and 3D printing as innovative 
technologies for fabricating 
personalized topical drug delivery 
systems. Journal of Controlled Release. 
2016;234:41-48
[33] Fina F, Goyanes A, Gaisford S, 
Basit AW. Selective laser sintering (SLS) 
3D printing of medicines. International 
Pharmaceutical Formulation Design - Recent Practices
12
Journal of Pharmaceutics. 
2017;529(1-2):285-293
[34] Salmoria GV, Klauss P, 
Zepon KM, Kanis LA. The effects 
of laser energy density and particle 
size in the selective laser sintering 
of polycaprolactone/progesterone 
specimens: Morphology and drug 
release. The International Journal of 
Advanced Manufacturing Technology. 
2013;66(5-8):1113-1118
[35] Goyanes A, Kobayashi M, 
Martínez-Pacheco R, Gaisford S, 
Basit AW. Fused-filament 3D  
printing of drug products: 
Microstructure analysis and drug 
release characteristics of PVA-based 
caplets. International Journal of 
Pharmaceutics. 2016;514(1):290-295
[36] Gioumouxouzis CI, Katsamenis OL, 
Bouropoulos N, Fatouros DG. 3D 
printed oral solid dosage forms 
containing hydrochlorothiazide for 
controlled drug delivery. Journal of 
Drug Delivery Science and Technology. 
2017;40:164-171
[37] Jamróz W, Kurek M, Łyszczarz E, 
Szafraniec J, Knapik-Kowalczuk J, 
Syrek K, et al. 3D printed orodispersible 
films with Aripiprazole. International 
Journal of Pharmaceutics. 
2017;533(2):413-420
[38] Wu BM, Borland SW, Giordano RA, 
Cima LG, Sachs EM, Cima MJ. Solid 
free-form fabrication of drug delivery 
devices. Journal of Controlled Release. 
1996;40(1-2):77-87
[39] Wang J, Goyanes A, Gaisford S, 
Basit AW. Stereolithographic (SLA) 
3D printing of oral modified-release 
dosage forms. International Journal of 
Pharmaceutics. 2016;503(1-2):207-212
[40] Katstra WE, Palazzolo RD, 
Rowe CW, Giritlioglu B, Teung P, 
Cima MJ. Oral dosage forms fabricated 
by three dimensional printing™. Journal 
of Controlled Release. 2000;66(1):1-9
[41] Jacob J et al. Aprecia 
Pharmaceuticals LLC. Rapid disperse 
dosage form containing levetiracetam. 
US9339489B2
[42] Huang W, Zheng Q , Sun W, Xu H, 
Yang X. Levofloxacin implants with 
predefined microstructure fabricated by 
three-dimensional printing technique. 
International Journal of Pharmaceutics. 
2007;339(1-2):33-38
[43] Wu W, Zheng Q , Guo X,  
Sun J, Liu Y. A programmed  
release multi-drug implant fabricated  
by three-dimensional printing 
technology for bone tuberculosis 
therapy. Biomedical Materials. 
2009;4(6):065005
[44] Pardeike J, Strohmeier DM, 
Schrödl N, Voura C, Gruber M, 
Khinast JG, et al. Nanosuspensions 
as advanced printing ink for 
accurate dosing of poorly soluble 
drugs in personalized medicines. 
International Journal of Pharmaceutics. 
2011;420(1):93-100
[45] Banks J. Adding value in additive 
manufacturing: Researchers in the 
United Kingdom and Europe look to 3D 
printing for customization. IEEE Pulse. 
2013;4(6):22-26
[46] Mertz L. Dream it, design it, print 
it in 3-D: What can 3-D printing do for 
you? IEEE Pulse. 2013;4(6):15-21
[47] Lee BK, Yun YH, Choi JS, 
Choi YC, Kim JD, Cho YW. Fabrication 
of drug-loaded polymer microparticles 
with arbitrary geometries using a 
piezoelectric inkjet printing system. 
International Journal of Pharmaceutics. 
2012;427(2):305-310
[48] Scoutaris N, Alexander MR, 
Gellert PR, Roberts CJ. Inkjet printing as 
a novel medicine formulation technique. 
Journal of Controlled Release. 
2011;156(2):179-185
13
3D Printing in Pharmaceutical Sector: An Overview
DOI: http://dx.doi.org/10.5772/intechopen.90738
[49] Katstra WE. Fabrication of complex 
oral drug delivery forms by Three 
Dimensional Printing (tm). Doctoral 
dissertation. Massachusetts Institute of 
Technology
[50] Yu DG, Branford-White C, Yang YC, 
Zhu LM, Welbeck EW, Yang XL. A novel 
fast disintegrating tablet fabricated 
by three-dimensional printing. Drug 
Development and Industrial Pharmacy. 
2009;35(12):1530-1536
[51] Ursan ID, Chiu L, Pierce A. Three-
dimensional drug printing: A 
structured review. Journal of the 
American Pharmacists Association. 
2013;53(2):136-144
[52] Cui X, Boland T, DD'Lima D, 
Lotz MK. Thermal inkjet printing in 
tissue engineering and regenerative 
medicine. Recent Patents on 
Drug Delivery and Formulation. 
2012;6(2):149-155
[53] Ozbolat IT, Yu Y. Bioprinting 
toward organ fabrication: Challenges 
and future trends. IEEE Transactions 
on Biomedical Engineering. 
2013;60(3):691-699
[54] Bartlett S. Printing organs on 
demand. The Lancet Respiratory 
Medicine. 2013;1(9):684
[55] Lipson H. New world of 3-D 
printing offers “completely new ways of 
thinking”: Q&A with author, engineer, 
and 3-D printing expert Hod Lipson. 
IEEE Pulse. 2013;4(6):12-14
